secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vicapsys Life Sciences, Inc. (VICP)
CIK:        0001468639
Form:       8-K
Filed at:   2023-06-02T23:59:59+00:00
Accession:  0001493152-23-019905
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vicapsys Life Sciences amends patent license with Massachusetts General Hospital, adding new patent rights
--------------------------------------------------------------------------------

- Ninth Amendment adds Patent Rights MGH 24644 (PCT/US2018/051950) to exclusive license.
- Company must submit a research and development plan for new patent rights within one year.
- Company pays $2,000 non-refundable license fee and reimburses $3,956 in patent costs by July 31, 2023.
- Amendment updates diligence requirements under Section 3.1 of the original 2013 agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468639/000149315223019905/0001493152-23-019905-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468639/000149315223019905/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-019905

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer